U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07292818) titled 'Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies' on Nov. 24.
Brief Summary: This pilot feasibility study evaluates the use of a hyaluronic acid-based spacing gel (Barrigel) in participants with cervical cancer undergoing chemoradiotherapy (chemoRT), including brachytherapy, as part of standard care.
The primary goal is to assess feasibility. Other goals include determining whether gel placement can reduce radiation dose to nearby healthy organs (organs at risk, OAR) and improve delivery of the prescribed radiation dose to the tumor.
In cervical cancer, the radiation dose to the tumor is often limited by the risk of e...